The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Sexual Dysfunction Drugs-Global Market Insights and Sales Trends 2024

Sexual Dysfunction Drugs-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1840481

No of Pages : 117

Ask Your Query
Synopsis
Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.
The global Sexual Dysfunction Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sexual Dysfunction Drugs in various end use industries. The expanding demands from the Male and Female, are propelling Sexual Dysfunction Drugs market. Oral Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intracavernosal Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by User. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sexual Dysfunction Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sexual Dysfunction Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sexual Dysfunction Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sexual Dysfunction Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sexual Dysfunction Drugs covered in this report include Pfizer, GlaxoSmithKline, Merck, Eli Lilly, AbbVie, Bayer, Teva Pharmaceutical Industries, Takeda and Apricus Biosciences, etc.
The global Sexual Dysfunction Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
AbbVie
Bayer
Teva Pharmaceutical Industries
Takeda
Apricus Biosciences
Emotional Brain
Ivix LLX
Leadiant Biosciences
NexMed
S1 Biopharma
Vietstar Biomedical Research
Global Sexual Dysfunction Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sexual Dysfunction Drugs market, Segment by Type:
Oral Therapy
Intracavernosal Therapy
Hormonal Therapy
Transurethral Therapy
Global Sexual Dysfunction Drugs market, by User
Male
Female
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Sexual Dysfunction Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by User, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Sexual Dysfunction Drugs Market Overview
1.1 Sexual Dysfunction Drugs Product Overview
1.2 Sexual Dysfunction Drugs Market Segment by Type
1.2.1 Oral Therapy
1.2.2 Intracavernosal Therapy
1.2.3 Hormonal Therapy
1.2.4 Transurethral Therapy
1.3 Global Sexual Dysfunction Drugs Market Size by Type
1.3.1 Global Sexual Dysfunction Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Sexual Dysfunction Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Sexual Dysfunction Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Sexual Dysfunction Drugs Sales Breakdown by Type (2018-2023)
2 Global Sexual Dysfunction Drugs Market Competition by Company
2.1 Global Top Players by Sexual Dysfunction Drugs Sales (2018-2023)
2.2 Global Top Players by Sexual Dysfunction Drugs Revenue (2018-2023)
2.3 Global Top Players by Sexual Dysfunction Drugs Price (2018-2023)
2.4 Global Top Manufacturers Sexual Dysfunction Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Sexual Dysfunction Drugs Market Competitive Situation and Trends
2.5.1 Sexual Dysfunction Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Sexual Dysfunction Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sexual Dysfunction Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Sexual Dysfunction Drugs Market
2.8 Key Manufacturers Sexual Dysfunction Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Sexual Dysfunction Drugs Status and Outlook by Region
3.1 Global Sexual Dysfunction Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Sexual Dysfunction Drugs Historic Market Size by Region
3.2.1 Global Sexual Dysfunction Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Sexual Dysfunction Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Sexual Dysfunction Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Sexual Dysfunction Drugs Forecasted Market Size by Region
3.3.1 Global Sexual Dysfunction Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Sexual Dysfunction Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Sexual Dysfunction Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Sexual Dysfunction Drugs by User
4.1 Sexual Dysfunction Drugs Market Segment by User
4.1.1 Male
4.1.2 Female
4.2 Global Sexual Dysfunction Drugs Market Size by User
4.2.1 Global Sexual Dysfunction Drugs Market Size Overview by User (2018-2029)
4.2.2 Global Sexual Dysfunction Drugs Historic Market Size Review by User (2018-2023)
4.2.3 Global Sexual Dysfunction Drugs Forecasted Market Size by User (2024-2029)
4.3 Key Regions Market Size Segment by User
4.3.1 North America Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
4.3.2 Europe Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
4.3.3 Asia-Pacific Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
4.3.4 Latin America Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
4.3.5 Middle East and Africa Sexual Dysfunction Drugs Sales Breakdown by User (2018-2023)
5 North America Sexual Dysfunction Drugs by Country
5.1 North America Sexual Dysfunction Drugs Historic Market Size by Country
5.1.1 North America Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
5.2 North America Sexual Dysfunction Drugs Forecasted Market Size by Country
5.2.1 North America Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)
6 Europe Sexual Dysfunction Drugs by Country
6.1 Europe Sexual Dysfunction Drugs Historic Market Size by Country
6.1.1 Europe Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
6.2 Europe Sexual Dysfunction Drugs Forecasted Market Size by Country
6.2.1 Europe Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Sexual Dysfunction Drugs by Region
7.1 Asia-Pacific Sexual Dysfunction Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Sexual Dysfunction Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Sexual Dysfunction Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Sexual Dysfunction Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Sexual Dysfunction Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Sexual Dysfunction Drugs Sales in Value by Region (2024-2029)
8 Latin America Sexual Dysfunction Drugs by Country
8.1 Latin America Sexual Dysfunction Drugs Historic Market Size by Country
8.1.1 Latin America Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Sexual Dysfunction Drugs Forecasted Market Size by Country
8.2.1 Latin America Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Sexual Dysfunction Drugs by Country
9.1 Middle East and Africa Sexual Dysfunction Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Sexual Dysfunction Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Sexual Dysfunction Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Sexual Dysfunction Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Sexual Dysfunction Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Sexual Dysfunction Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Sexual Dysfunction Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Sexual Dysfunction Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck Sexual Dysfunction Drugs Products Offered
10.3.5 Merck Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly Sexual Dysfunction Drugs Products Offered
10.4.5 Eli Lilly Recent Development
10.5 AbbVie
10.5.1 AbbVie Company Information
10.5.2 AbbVie Introduction and Business Overview
10.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AbbVie Sexual Dysfunction Drugs Products Offered
10.5.5 AbbVie Recent Development
10.6 Bayer
10.6.1 Bayer Company Information
10.6.2 Bayer Introduction and Business Overview
10.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bayer Sexual Dysfunction Drugs Products Offered
10.6.5 Bayer Recent Development
10.7 Teva Pharmaceutical Industries
10.7.1 Teva Pharmaceutical Industries Company Information
10.7.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Products Offered
10.7.5 Teva Pharmaceutical Industries Recent Development
10.8 Takeda
10.8.1 Takeda Company Information
10.8.2 Takeda Introduction and Business Overview
10.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Takeda Sexual Dysfunction Drugs Products Offered
10.8.5 Takeda Recent Development
10.9 Apricus Biosciences
10.9.1 Apricus Biosciences Company Information
10.9.2 Apricus Biosciences Introduction and Business Overview
10.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Apricus Biosciences Sexual Dysfunction Drugs Products Offered
10.9.5 Apricus Biosciences Recent Development
10.10 Emotional Brain
10.10.1 Emotional Brain Company Information
10.10.2 Emotional Brain Introduction and Business Overview
10.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Emotional Brain Sexual Dysfunction Drugs Products Offered
10.10.5 Emotional Brain Recent Development
10.11 Ivix LLX
10.11.1 Ivix LLX Company Information
10.11.2 Ivix LLX Introduction and Business Overview
10.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ivix LLX Sexual Dysfunction Drugs Products Offered
10.11.5 Ivix LLX Recent Development
10.12 Leadiant Biosciences
10.12.1 Leadiant Biosciences Company Information
10.12.2 Leadiant Biosciences Introduction and Business Overview
10.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Products Offered
10.12.5 Leadiant Biosciences Recent Development
10.13 NexMed
10.13.1 NexMed Company Information
10.13.2 NexMed Introduction and Business Overview
10.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 NexMed Sexual Dysfunction Drugs Products Offered
10.13.5 NexMed Recent Development
10.14 S1 Biopharma
10.14.1 S1 Biopharma Company Information
10.14.2 S1 Biopharma Introduction and Business Overview
10.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 S1 Biopharma Sexual Dysfunction Drugs Products Offered
10.14.5 S1 Biopharma Recent Development
10.15 Vietstar Biomedical Research
10.15.1 Vietstar Biomedical Research Company Information
10.15.2 Vietstar Biomedical Research Introduction and Business Overview
10.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Products Offered
10.15.5 Vietstar Biomedical Research Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Sexual Dysfunction Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Sexual Dysfunction Drugs Industrial Chain Analysis
11.4 Sexual Dysfunction Drugs Market Dynamics
11.4.1 Sexual Dysfunction Drugs Industry Trends
11.4.2 Sexual Dysfunction Drugs Market Drivers
11.4.3 Sexual Dysfunction Drugs Market Challenges
11.4.4 Sexual Dysfunction Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Sexual Dysfunction Drugs Distributors
12.3 Sexual Dysfunction Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock